Free Trial

Avantax Advisory Services Inc. Acquires 3,427 Shares of Colgate-Palmolive (NYSE:CL)

Colgate-Palmolive logo with Consumer Staples background
Remove Ads

Avantax Advisory Services Inc. boosted its holdings in Colgate-Palmolive (NYSE:CL - Free Report) by 6.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 56,782 shares of the company's stock after acquiring an additional 3,427 shares during the quarter. Avantax Advisory Services Inc.'s holdings in Colgate-Palmolive were worth $5,162,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Kohmann Bosshard Financial Services LLC bought a new stake in shares of Colgate-Palmolive during the 4th quarter worth $26,000. Centricity Wealth Management LLC acquired a new position in shares of Colgate-Palmolive in the 4th quarter valued at $27,000. Union Bancaire Privee UBP SA purchased a new position in Colgate-Palmolive in the 4th quarter worth about $32,000. Briaud Financial Planning Inc acquired a new stake in Colgate-Palmolive during the 4th quarter worth about $32,000. Finally, Bernard Wealth Management Corp. purchased a new stake in Colgate-Palmolive during the fourth quarter valued at about $36,000. 80.41% of the stock is owned by institutional investors and hedge funds.

Colgate-Palmolive Stock Up 1.1 %

NYSE CL traded up $0.95 during trading on Wednesday, hitting $90.44. 8,242,126 shares of the company traded hands, compared to its average volume of 4,191,857. Colgate-Palmolive has a 12 month low of $85.32 and a 12 month high of $109.30. The business has a fifty day simple moving average of $89.13 and a 200 day simple moving average of $94.44. The company has a market capitalization of $73.39 billion, a P/E ratio of 25.69, a PEG ratio of 4.20 and a beta of 0.40. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40.

Remove Ads

Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period last year, the company posted $0.87 earnings per share. As a group, sell-side analysts predict that Colgate-Palmolive will post 3.75 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on the stock. Morgan Stanley dropped their target price on shares of Colgate-Palmolive from $111.00 to $104.00 and set an "overweight" rating on the stock in a research report on Monday, February 3rd. Royal Bank of Canada reissued a "sector perform" rating and set a $101.00 target price on shares of Colgate-Palmolive in a research note on Wednesday, January 29th. Raymond James restated an "outperform" rating and issued a $105.00 target price (down previously from $110.00) on shares of Colgate-Palmolive in a report on Monday, February 3rd. Piper Sandler lowered their price target on Colgate-Palmolive from $121.00 to $112.00 and set an "overweight" rating on the stock in a report on Monday, January 6th. Finally, StockNews.com downgraded Colgate-Palmolive from a "buy" rating to a "hold" rating in a research note on Friday, March 14th. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and eleven have issued a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Hold" and an average price target of $101.72.

Check Out Our Latest Stock Report on Colgate-Palmolive

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Read More

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Should You Invest $1,000 in Colgate-Palmolive Right Now?

Before you consider Colgate-Palmolive, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.

While Colgate-Palmolive currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
Why Palantir’s Future Just Got a Massive Boost

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads